FDA Inspection
Medline Industries, LPMedline Industries, LP – FDA Inspection, Jul 18, 2025
Record Details
This FDA Inspection record concerns Medline Industries, LP, with an inspection on July 18, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 849d1867-6ecd-4688-b9e1-9c1ad5dc8620
Inspection Facts
- Inspection number
- 1269620
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.122(d)Labels and labeling stored separately
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.194(a)(1)Sample identification and other information
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(2)Rejected Material Area
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medline Industries, LP
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 25, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medline Industries, LP
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.